AstraZeneca's £32M HQ Defect Claim Misguided, Fire Co. Says
A fire engineering consultancy has denied designing problematic fire-stopping protection at AstraZeneca UK Ltd.'s £1 billion ($1.35 billion) headquarters, and said that the pharmaceutical company's £31.7 million claim is a misconceived...To view the full article, register now.
Already a subscriber? Click here to view full article